Psilocybin Exposures Reported to U.S. Poison Centers: National Trends Over a Decade.
J Adolesc Health
; 74(5): 1053-1056, 2024 May.
Article
en En
| MEDLINE
| ID: mdl-38416101
ABSTRACT
PURPOSE:
We describe trends in psilocybin exposures among adolescents and young adults as reported to US poison centers over the past decade.METHODS:
We queried the National Poison Data System for cases involving psilocybin during January 1, 2013-December 31, 2022. Persons aged 13-25 years were included. We examined exposures to psilocybin by demographics, clinical effects, level of care, and medical outcome.RESULTS:
During the 10-year study period, 4,055 psilocybin-involved exposures were reported among adolescents and young adults, 2,667 (65.8%) being single substance exposures. Most single substance cases received medical attention (adolescents 75.3% [n = 1,176], young adults 72.1% [n = 797]). We did not find significant change in the number of cases during 2013-2018. Cases started increasing in 2019. In 2022, cases more than tripled among adolescents and more than doubled among young adults, compared to 2018 (p < .0001).DISCUSSION:
Continued national surveillance is critical to determine the impact of psilocybin exposures on youth as it becomes increasingly available.Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Venenos
/
Psilocibina
Límite:
Adolescent
/
Adult
/
Humans
País/Región como asunto:
America do norte
Idioma:
En
Revista:
J Adolesc Health
Asunto de la revista:
PEDIATRIA
Año:
2024
Tipo del documento:
Article